Search clinical trials for: Rifampin/isoniazid FDC

Total 3535 results

Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Pulmonary Tuberculosis

China
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment (REMEMBER)

HIV Infection

Peru, Malawi, Uganda, South Africa, India, Haiti, Zambia, Zimbabwe, Brazil, Kenya
Miguel Santín
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Not yet recruiting

Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease

Latent Tuberculosis | Kidney Failure
Sociedad Andaluza de Enfermedades Infecciosas

Completed

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

HIV Infections | Tuberculosis

Spain
Sociedad Andaluza de Enfermedades Infecciosas

Completed

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

HIV Infections

Spain
Institute of Tropical Medicine, Belgium
Damien Foundation

Active, not recruiting

Novel Triple-dose Tuberculosis Retreatment Regimen (Tri-Do-Re)

Tuberculosis | Pulmonary Tuberculosis | Multidrug-resistant Tuberculosis | Resistance to Tuberculostatic Drugs

Niger
Taipei Medical University WanFang Hospital

Unknown

Pharmacokinetic Study for Anti-tuberculosis Drugs (TBPK)

Pulmonary Tuberculosis

Taiwan
University of Florida
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Tuberculosis | Human Immunodeficiency Virus | Coinfection

Ghana
Janssen Scientific Affairs, LLC

Completed

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain (DEFINE)

HIV-1

United States
University of Washington
Fred Hutchinson Cancer Center; National Institute of General Medical Sciences...

Completed

Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

Adverse Drug Interactions

United States
Universitas Padjadjaran
Radboud University Medical Center

Completed

Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation (REMOVER)

Tuberculous Meningitis

Indonesia
Hospital Virgen de la Luz

Terminated

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

Tuberculosis

Spain
Radboud University Medical Center

Completed

Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

Prostatic Neoplasms | Immunotherapy | Vaccines | Dendritic Cells

Netherlands
Centers for Disease Control and Prevention
British Medical Research Council

Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI (ASTERoiD)

Latent Tuberculosis

Australia, United States, Canada, South Africa
University of Cape Town

Completed

The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB) (BIO3FDC)

Tuberculosis

South Africa
Instituto Nacional de Salud Publica, Mexico
Instituto Nacional de Enfermedades Respiratorias; Instituto Nacional de Ciencias...

Completed

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL) (TBL)

Diabetes Mellitus | Tuberculin (Skin Test) Positive

Mexico
University Hospital, Linkoeping
Linkoeping University

Suspended

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide (HIGHSHORT-RP)

Tuberculosis, Pulmonary

Sweden
Huashan Hospital

Recruiting

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts (TB-YOUTH)

Latent Tuberculosis | Tuberculosis

China
Global Alliance for TB Drug Development

Completed

Shortening Treatment by Advancing Novel Drugs (STAND)

Tuberculosis, Pulmonary, Drug Sensitive | Tuberculosis, Pulmonary, Multi Drug-resistant

South Africa, Zambia, Georgia, Philippines, Kenya, Malaysia, Tanzania, Uganda
National Institute of Allergy and Infectious Diseases...

Recruiting

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Tuberculous Meningitis

South Africa, Zimbabwe, India, Kenya, Malawi, Mexico, Peru, Brazil, Philippines, Tanzania, Thailand, Vietnam
Oswaldo Cruz Foundation

Completed

A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers

Tuberculosis

Brazil
Osaka University

Completed

Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)

Pulmonary Tuberculosis

Japan
Global Alliance for TB Drug Development
Sanofi; University College, London; European and Developing Countries Clinical... and other collaborators

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (REMoxTB)

Pulmonary Tuberculosis

China, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand
Yuria-Pharm

Terminated

Efficacy and Safety of Intravenous Treatment of Tuberculosis

Tuberculosis, Pulmonary

Ukraine
Pfizer

Completed

Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)

Tuberculosis

Philippines
Bill & Melinda Gates Medical Research Institute
Global Alliance for TB Drug Development; Janssen Pharmaceutica; Otsuka Pharmaceutical...

Recruiting

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa, Philippines
Instituto Nacional de Salud Publica, Mexico

Withdrawn

Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis

Diabetes Mellitus | Latent Tuberculosis
Laboratorios Silanes S.A. de C.V.

Completed

Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program

Tuberculosis

Mexico
Johns Hopkins University
Universidade Federal do Rio de Janeiro

Terminated

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

Tuberculosis

Brazil
Herlev and Gentofte Hospital

Completed

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

Diabetes Mellitus, Type 2 | Latent Tuberculosis

Denmark
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); Federal University... and other collaborators

Recruiting

Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention

Tuberculosis Infection | Isoniazid Adverse Reaction

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

Phase 2a EBA Trial of AZD5847

Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Pulmonary Tuberculosis

South Africa
The Aurum Institute NPC
London School of Hygiene and Tropical Medicine; Johns Hopkins University; Aurum...

Completed

Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals (WHIP3TB)

HIV | Tuberculosis

South Africa
National Taiwan University Hospital

Completed

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison (LTBI_prison)

Tuberculosis

Taiwan
University of Cape Town

Recruiting

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis (NEW-STRAT TB)

HIV | Disseminated Tuberculosis

South Africa
National Taiwan University Hospital

Unknown

Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment

Hepatitis | Tuberculosis, Pulmonary

Taiwan
University of Oxford

Completed

PK Study of Anti-TB Drugs

Tuberculosis

Thailand
Makerere University

Unknown

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes (SOUTH)

AIDS With Tuberculosis

Uganda
Tuberculosis Research Centre, India

Unknown

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Tuberculosis | Human Immunodeficiency Virus Infections

India
Seoul National University Hospital
Pusan National University Hospital; Chonnam National University Hospital; Seoul... and other collaborators

Not yet recruiting

Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) (Hi-DoRi-3)

Tuberculosis, Pulmonary

Korea, Republic of
Genentech, Inc.

Completed

A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential

Healthy
Janssen Sciences Ireland UC

Completed

A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Immunodeficiency Virus Type 1, Human

United States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
Bridge BioResearch Ltd.

Unknown

Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study (BBR-012)

Diabetic Foot Ulcer

United Kingdom
Harvard University Faculty of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); Sanofi; University... and other collaborators

Completed

Trial of High-Dose Rifampin in Patients With TB (HIRIF)

Tuberculosis

United States, Peru, United Kingdom
National Taiwan University Hospital

Unknown

Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)

Latent Tuberculosis Infection

Taiwan
Janssen Scientific Affairs, LLC

Completed

A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

HIV-1

United States
University of Giessen
Indonesian Directorate General of Higher Education

Completed

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia (FSS)

Body Weight Changes | Motor Activity | Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases...

Completed

Using Biomarkers to Predict TB Treatment Duration

Pulmonary Tuberculosis

South Africa
University of South Florida
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Arthritis, Reactive | Reiter Disease

United States, Canada

Search clinical trials for: Rifampin/isoniazid FDC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations